Aromatic L-amino acid decarboxylase inhibitor

From WikiMD's WELLNESSPEDIA

An aromatic L-amino acid decarboxylase inhibitor (AADC inhibitor) is a type of drug that inhibits the enzyme aromatic L-amino acid decarboxylase (AADC). This enzyme is responsible for the decarboxylation of aromatic L-amino acids, such as L-DOPA, into their corresponding amines, such as dopamine. AADC inhibitors are used in combination with L-DOPA in the treatment of Parkinson's disease to prevent the peripheral conversion of L-DOPA to dopamine, thereby increasing the availability of L-DOPA to the central nervous system.

Levodopa pathway

Mechanism of Action[edit]

Aromatic L-amino acid decarboxylase inhibitors work by binding to the AADC enzyme and inhibiting its activity. This prevents the conversion of L-DOPA to dopamine outside the brain. Since dopamine cannot cross the blood-brain barrier, inhibiting its peripheral synthesis ensures that more L-DOPA is available to enter the brain, where it can be converted to dopamine by the AADC enzyme present in the central nervous system.

Clinical Use[edit]

AADC inhibitors are primarily used in the management of Parkinson's disease. They are administered in combination with L-DOPA, the precursor to dopamine, to enhance its efficacy. By preventing the peripheral conversion of L-DOPA to dopamine, AADC inhibitors reduce the side effects associated with peripheral dopamine, such as nausea and cardiovascular effects.

Common AADC Inhibitors[edit]

Pharmacokinetics[edit]

AADC inhibitors do not cross the blood-brain barrier, which is why they selectively inhibit peripheral AADC activity. This selective inhibition is crucial for their therapeutic effect, as it allows for increased central availability of L-DOPA without affecting the central conversion of L-DOPA to dopamine.

Side Effects[edit]

The use of AADC inhibitors can lead to side effects, although these are generally related to the increased levels of L-DOPA. Common side effects include:

  • Nausea
  • Orthostatic hypotension
  • Dyskinesias

Related Pages[edit]

Apple Developer brandmark





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.